James Patrick Allison
Affiliations: | 1985-1997 | Molecular and Cell Biology | University of California, Berkeley, Berkeley, CA, United States |
| 1997-2004 | Rheumatology | University of California, San Francisco, San Francisco, CA | |
| 2004-2012 | Weill Cornell Medical College, New York, NY, United States | ||
| 2006-2012 | Memorial Sloan-Kettering Cancer Center, Rockville Centre, NY, United States | ||
| 2012- | Immunology | M. D. Anderson Cancer Center, Houston, TX, United States |
Area:
ImmunotherapyWebsite:
https://faculty.mdanderson.org/profiles/james_allison.htmlGoogle:
"James Patrick Allison"Bio:
The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation"
http://www.nasonline.org/member-directory/members/3003904.html
http://www.whatisbiotechnology.org/index.php/people/summary/Allison
https://kingfaisalprize.org/professor-james-p-allison/
http://digitalassets.lib.berkeley.edu/rohoia/ucb/text/oralhisttransretro00maririch.pdf
Mean distance: (not calculated yet)
Cross-listing: ImmunoTree
Parents
Sign in to add mentor| G Barrie Kitto | grad student | 1973 | UT Austin | |
| (I. Isolation and characterization of a tumor inhibitory asparaginase from Alcaligenes eutrophus. II. Insolubilization of L-Asparaginase by covalent attachment to nylon tubing.) | ||||
| Ralph Alfred Reisfeld | post-doc | 1974-1977 | Scripps Institute | |
Children
Sign in to add trainee| Jackson G. Egen | grad student | 2002 | UC Berkeley |
| Dilnawaz Kapadia | grad student | 2003 | UC Berkeley |
| Virginia A. Pedicord | grad student | 2010 | Weill Cornell Medical College |
| Rachel A. Gottschalk | grad student | 2012 | Weill Cornell Medical College |
| Xiaozhou Fan | grad student | 2013 | Weill Cornell Medical College |
| Tyler R. Simpson | grad student | 2013 | Weill Cornell Medical College |
Collaborators
Sign in to add collaborator| Grégoire Altan-Bonnet | collaborator | 2006-2012 | Memorial Sloan Kettering Cancer Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Axelrod ML, Meijers WC, Screever EM, et al. (2022) T cells specific for α-myosin drive immunotherapy-related myocarditis. Nature |
| Hailemichael Y, Johnson DH, Abdel-Wahab N, et al. (2022) Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell. 40: 509-523.e6 |
| Abbas HA, Hao D, Tomczak K, et al. (2021) Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy. Nature Communications. 12: 6071 |
| Sharma N, Atolagbe OT, Ge Z, et al. (2021) LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy. The Journal of Experimental Medicine. 218 |
| Goswami S, Chen Y, Anandhan S, et al. (2020) mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC. Science Translational Medicine. 12 |
| Mitra A, Andrews MC, Roh W, et al. (2020) Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma. Nature Communications. 11: 1839 |
| Subudhi SK, Vence L, Zhao H, et al. (2020) Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer. Science Translational Medicine. 12 |
| Reuben A, Zhang J, Chiou SH, et al. (2020) Comprehensive T cell repertoire characterization of non-small cell lung cancer. Nature Communications. 11: 603 |
| Helmink BA, Reddy SM, Gao J, et al. (2020) B cells and tertiary lymphoid structures promote immunotherapy response. Nature |
| Sharma P, Allison JP. (2020) Dissecting the mechanisms of immune checkpoint therapy. Nature Reviews. Immunology |